Cypher In-Stent Restenosis Treatment Safety Upheld By J&J Investigators

Eight-month follow-up of Johnson & Johnson/Cordis' 41-patient study evaluating the Cypher sirolimus-eluting stent for treating in-stent restenosis suggests the procedure is safe and effective, investigators reported March 19 at the American College of Cardiology annual scientific sessions in Atlanta